Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-11-27

Clinical Trial Update: Ibuprofen Versus Ibuprofen Plus Caffeine in the Treatment of Migraine. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing ibuprofen alone versus ibuprofen with caffeine for migraine was withdrawn; no study results were reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Caffeine (caffeine)
  • Ibuprofen (IBUPROFEN)

Snippet

Sponsor: Sanofi | Conditions: Pain | Phase 3 | Status: WITHDRAWN